Importer Of Controlled Substances; Notice Of Registration; Cerilliant Corporation, 70186-70187 [2012-28482]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
70186
Federal Register / Vol. 77, No. 226 / Friday, November 23, 2012 / Notices
2012. The Commission’s views are due
at Commerce within five business days
thereafter, or by January 8, 2013.
For further information concerning
the conduct of this investigation and
rules of general application, consult the
Commission’s Rules of Practice and
Procedure, part 201, subparts A through
E (19 CFR part 201), and part 207,
subparts A and B (19 CFR part 207).
DATES: Effective Date: November 15,
2012.
FOR FURTHER INFORMATION CONTACT:
Mary Messer (202–205–3193), Office of
Investigations, U.S. International Trade
Commission, 500 E Street SW.,
Washington, DC 20436. Hearingimpaired persons can obtain
information on this matter by contacting
the Commission’s TDD terminal on 202–
205–1810. Persons with mobility
impairments who will need special
assistance in gaining access to the
Commission should contact the Office
of the Secretary at 202–205–2000.
General information concerning the
Commission may also be obtained by
accessing its internet server (https://
www.usitc.gov). The public record for
this investigation may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov.
SUPPLEMENTARY INFORMATION:
Background. This investigation is
being instituted in response to a petition
filed on November 15, 2012, by Utah
Refractories Corp., Lehi, UT.
Participation in the investigation and
public service list. Persons (other than
petitioners) wishing to participate in the
investigation as parties must file an
entry of appearance with the Secretary
to the Commission, as provided in
sections 201.11 and 207.10 of the
Commission’s rules, not later than seven
days after publication of this notice in
the Federal Register. Industrial users
and (if the merchandise under
investigation is sold at the retail level)
representative consumer organizations
have the right to appear as parties in
Commission antidumping
investigations. The Secretary will
prepare a public service list containing
the names and addresses of all persons,
or their representatives, who are parties
to this investigation upon the expiration
of the period for filing entries of
appearance.
Limited disclosure of business
proprietary information (BPI) under an
administrative protective order (APO)
and BPI service list. Pursuant to section
207.7(a) of the Commission’s rules, the
Secretary will make BPI gathered in this
investigation available to authorized
applicants representing interested
parties (as defined in 19 U.S.C. 677(9))
VerDate Mar<15>2010
17:03 Nov 21, 2012
Jkt 229001
who are parties to the investigation
under the APO issued in the
investigation, provided that the
application is made not later than seven
days after the publication of this notice
in the Federal Register. A separate
service list will be maintained by the
Secretary for those parties authorized to
receive BPI under the APO.
Conference. The Commission’s
Director of Investigations has scheduled
a conference in connection with this
investigation for 9:30 a.m. on December
6, 2012, at the U.S. International Trade
Commission Building, 500 E Street SW.,
Washington, DC. Requests to appear at
the conference should be filed with the
Office of the Secretary
(William.bishop@usitc.gov and
Sharon.bellamy@usitc.gov) on or before
December 4, 2012. Parties in support of
the imposition of antidumping duties in
this investigation and parties in
opposition to the imposition of such
duties will each be collectively
allocated one hour within which to
make an oral presentation at the
conference. A nonparty who has
testimony that may aid the
Commission’s deliberations may request
permission to present a short statement
at the conference.
Written submissions. As provided in
sections 201.8 and 207.15 of the
Commission’s rules, any person may
submit to the Commission on or before
December 11, 2012, a written brief
containing information and arguments
pertinent to the subject matter of the
investigation. Parties may file written
testimony in connection with their
presentation at the conference no later
than three days before the conference. If
briefs or written testimony contain BPI,
they must conform with the
requirements of sections 201.6, 207.3,
and 207.7 of the Commission’s rules.
Please consult the Commission’s rules,
as amended, 76 FR 61937 (Oct. 6, 2011)
and the Commission’s Handbook on
Filing Procedures, 76 FR 62092 (Oct. 6,
2011), available on the Commission’s
Web site at https://edis.usitc.gov.
In accordance with sections 201.16(c)
and 207.3 of the rules, each document
filed by a party to the investigation must
be served on all other parties to the
investigation (as identified by either the
public or BPI service list), and a
certificate of service must be timely
filed. The Secretary will not accept a
document for filing without a certificate
of service.
Authority: This investigation is being
conducted under authority of title VII of the
Tariff Act of 1930; this notice is published
pursuant to section 207.12 of the
Commission’s rules.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Issued: November 19, 2012.
By order of the Commission.
Lisa R. Barton,
Acting Secretary to the Commission.
[FR Doc. 2012–28419 Filed 11–21–12; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer Of Controlled Substances;
Notice Of Registration; Cerilliant
Corporation
By Notice dated August 17, 2012, and
published in the Federal Register on
August 20, 2012, 77 FR 50162, Cerilliant
Corporation, 811 Paloma Drive, Suite A,
Round Rock, Texas 78665–2402, made
application by renewal; to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the
following basic classes of controlled
substances:
Drug
Cathinone (1235) ..........................
Methcathinone (1237) ..................
4-Methyl-N-methylcathinone
(1248).
N-Ethylamphetamine (1475) ........
N,N-Dimethylamphetamine (1480)
Fenethylline (1503) .......................
Gamma
Hydroxybutyric
Acid
(2010).
JWH–018 (7118) ..........................
JWH–073 (7173) ..........................
JWH–200 (7200) ..........................
Alpha-ethyltryptamine (7249) .......
Ibogaine (7260) ............................
CP–47497 (7297) .........................
CP–47497 C8 Homologue (7298)
Lysergic acid diethylamide (7315)
2C-T-7(2,5-Dimethoxy-4-(n)propylthiophenethylamine)
(7348).
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Mescaline (7381) ..........................
3,4,5-Trimethoxyamphetamine
(7390).
4-Bromo-2,5dimethoxyamphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine
(7392).
4-Methyl-2,5dimethoxyamphetamine (7395).
2,5-Dimethoxyamphetamine
(7396).
3,4-Methylenedioxyamphetamine
(7400).
3,4-Methylenedioxy-Nethylamphetamine (7404).
3,4Methylenedioxymethamphetamine (7405).
4-Methoxyamphetamine (7411) ...
5-Methoxy-N-Ndimethyltryptamine (7431).
E:\FR\FM\23NON1.SGM
23NON1
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
70187
Federal Register / Vol. 77, No. 226 / Friday, November 23, 2012 / Notices
Drug
Schedule
mstockstill on DSK4VPTVN1PROD with NOTICES
Alpha-methyltryptamine (7432) ....
Diethyltryptamine (7434) ..............
Dimethyltryptamine (7435) ...........
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
5-Methoxy-N,Ndiisopropyltryptamine (7439).
N-Benzylpiperazine (7493) ...........
MDPV
3,4Methylenedioxypyrovalerone
(7535).
Methylone 3,4-Methylenedioxy-Nmethylcathinone (7540).
Desomorphine (9055) ...................
Etorphine (except HCl)(9056) ......
Heroin (9200) ...............................
Morphine-N-oxide (9307) .............
Normorphine (9313) .....................
Pholcodine (9314) ........................
Dextromoramide (9613) ...............
Dipipanone (9622) ........................
Racemoramide (9645) ..................
Trimeperidine (9646) ....................
1-Methyl-4-phenyl-4propionoxypiperidine (9661).
Tilidine (9750) ...............................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Phencyclidine (7471) ....................
Phenylacetone (8501) ..................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Benzoylecgonine (9180) ...............
Ethylmorphine (9190) ...................
Meperidine (9230) ........................
Methadone (9250) ........................
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Oripavine (9330) ...........................
Thebaine (9333) ...........................
Levo-alphacetylmethadol (9648) ..
Oxymorphone (9652) ...................
Poppy Straw Concentrate (9670)
Alfentanil (9737) ...........................
Sufentanil (9740) ..........................
Fentanyl (9801) ............................
I
I
I
I
I
I
I
I
I
Dated: November 14, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
I
I
I
I
I
I
I
I
I
I
I
[FR Doc. 2012–28482 Filed 11–21–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Importer of Controlled Substances;
Notice of Registration; Lipomed, Inc.
By Notice dated July 30, 2012, and
published in the Federal Register on
August 20, 2012, 77 FR 50162, Lipomed,
Inc., One Broadway, Cambridge,
Massachusetts 02142, made application
by letter to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the following basic
classes of controlled substances:
Drug
17:49 Nov 21, 2012
II
II
II
II
II
II
II
II
II
Jkt 229001
Schedule
Bufotenine (7433) .........................
Diethyltryptamine (7434) ..............
1-Piperidinocyclohexanecarbonitrile (8603).
The company plans to import small
quantities of the listed controlled
substances for the manufacture of
analytical reference standards.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Cerilliant Corporation to import the
basic classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. DEA
has investigated Cerilliant Corporation
to ensure that the company’s
registration is consistent with the public
VerDate Mar<15>2010
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above named
company is granted registration as an
importer of the basic classes of
controlled substances listed.
I
I
II
The company plans to import
analytical reference standards for
distribution to its customers for research
and analytical purposes.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Lipomed, Inc., to import the basic
classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. DEA
has investigated Lipomed, Inc., to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
with 21 CFR 1301.34, the above named
company is granted registration as an
importer of the basic classes of
controlled substances listed.
Dated: November 14, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–28484 Filed 11–21–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration; Mylan
Technologies, Inc.
By Notice dated March 8, 2012, and
published in the Federal Register on
March 20, 2012, 77 FR 16262, Mylan
Technologies, Inc., 110 Lake Street,
Saint Albans, Vermont 05478, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the
following basic classes of controlled
substances:
Drug
Methylphenidate (1724) ................
Fentanyl (9801) ............................
Schedule
II
II
The company plans to import the
listed controlled substances in finished
dosage form (FDF) from foreign sources
for analytical testing and clinical trials
in which the foreign FDF will be
compared to the company’s own
domestically-manufactured FDF. This
analysis is required to allow the
company to export domesticallymanufactured FDF to foreign markets.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
Mylan Pharmaceuticals, Inc. to import
the basic classes of controlled
substances is consistent with the public
interest, and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971. DEA has investigated
Mylan Pharmaceuticals, Inc. to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above named
E:\FR\FM\23NON1.SGM
23NON1
]]>Agencies
[Federal Register Volume 77, Number 226 (Friday, November 23, 2012)]
[Notices]
[Pages 70186-70187]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-28482]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer Of Controlled Substances; Notice Of Registration;
Cerilliant Corporation
By Notice dated August 17, 2012, and published in the Federal
Register on August 20, 2012, 77 FR 50162, Cerilliant Corporation, 811
Paloma Drive, Suite A, Round Rock, Texas 78665-2402, made application
by renewal; to the Drug Enforcement Administration (DEA) to be
registered as an importer of the following basic classes of controlled
substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)........................... I
Methcathinone (1237)....................... I
4-Methyl-N-methylcathinone (1248).......... I
N-Ethylamphetamine (1475).................. I
N,N-Dimethylamphetamine (1480)............. I
Fenethylline (1503)........................ I
Gamma Hydroxybutyric Acid (2010)........... I
JWH-018 (7118)............................. I
JWH-073 (7173)............................. I
JWH-200 (7200)............................. I
Alpha-ethyltryptamine (7249)............... I
Ibogaine (7260)............................ I
CP-47497 (7297)............................ I
CP-47497 C8 Homologue (7298)............... I
Lysergic acid diethylamide (7315).......... I
2C-T-7(2,5-Dimethoxy-4-(n)- I
propylthiophenethylamine) (7348).
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
Mescaline (7381)........................... I
3,4,5-Trimethoxyamphetamine (7390)......... I
4-Bromo-2,5-dimethoxyamphetamine (7391).... I
4-Bromo-2,5-dimethoxyphenethylamine (7392). I
4-Methyl-2,5-dimethoxyamphetamine (7395)... I
2,5-Dimethoxyamphetamine (7396)............ I
3,4-Methylenedioxyamphetamine (7400)....... I
3,4-Methylenedioxy-N-ethylamphetamine I
(7404).
3,4-Methylenedioxymethamphetamine (7405)... I
4-Methoxyamphetamine (7411)................ I
5-Methoxy-N-N-dimethyltryptamine (7431).... I
[[Page 70187]]
Alpha-methyltryptamine (7432).............. I
Diethyltryptamine (7434)................... I
Dimethyltryptamine (7435).................. I
Psilocybin (7437).......................... I
Psilocyn (7438)............................ I
5-Methoxy-N,N-diisopropyltryptamine (7439). I
N-Benzylpiperazine (7493).................. I
MDPV 3,4-Methylenedioxypyrovalerone (7535). I
Methylone 3,4-Methylenedioxy-N- I
methylcathinone (7540).
Desomorphine (9055)........................ I
Etorphine (except HCl)(9056)............... I
Heroin (9200).............................. I
Morphine-N-oxide (9307).................... I
Normorphine (9313)......................... I
Pholcodine (9314).......................... I
Dextromoramide (9613)...................... I
Dipipanone (9622).......................... I
Racemoramide (9645)........................ I
Trimeperidine (9646)....................... I
1-Methyl-4-phenyl-4-propionoxypiperidine I
(9661).
Tilidine (9750)............................ I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Methylphenidate (1724)..................... II
Amobarbital (2125)......................... II
Pentobarbital (2270)....................... II
Secobarbital (2315)........................ II
Phencyclidine (7471)....................... II
Phenylacetone (8501)....................... II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Benzoylecgonine (9180)..................... II
Ethylmorphine (9190)....................... II
Meperidine (9230).......................... II
Methadone (9250)........................... II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300)............................ II
Oripavine (9330)........................... II
Thebaine (9333)............................ II
Levo-alphacetylmethadol (9648)............. II
Oxymorphone (9652)......................... II
Poppy Straw Concentrate (9670)............. II
Alfentanil (9737).......................... II
Sufentanil (9740).......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to import small quantities of the listed
controlled substances for the manufacture of analytical reference
standards.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of Cerilliant Corporation to import the basic classes of
controlled substances is consistent with the public interest and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. DEA has investigated Cerilliant
Corporation to ensure that the company's registration is consistent
with the public interest. The investigation has included inspection and
testing of the company's physical security systems, verification of the
company's compliance with state and local laws, and a review of the
company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above named company is granted
registration as an importer of the basic classes of controlled
substances listed.
Dated: November 14, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-28482 Filed 11-21-12; 8:45 am]
BILLING CODE 4410-09-P
